Business Description
Faes Farma SA
SIC : 3841
ISIN : ES0134950F36
Compare
Compare
Traded in other countries / regions
FAE.Spain0K9H.UKFFEA.Germany IPO Date
2015-04-02Description
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | 0.2 | |||||
| Interest Coverage | 175.7 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 7.31 | |||||
| Beneish M-Score | -2.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 3.6 | |||||
| 3-Year EBITDA Growth Rate | 4.7 | |||||
| 3-Year EPS without NRI Growth Rate | 4 | |||||
| 3-Year Book Growth Rate | 9.6 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 93.95 | |||||
| 9-Day RSI | 87.51 | |||||
| 14-Day RSI | 81.54 | |||||
| 6-1 Month Momentum % | 4.85 | |||||
| 12-1 Month Momentum % | -2.49 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.34 | |||||
| Quick Ratio | 1.86 | |||||
| Cash Ratio | 0.55 | |||||
| Days Inventory | 295.49 | |||||
| Days Sales Outstanding | 89.42 | |||||
| Days Payable | 103.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.15 | |||||
| Forward Dividend Yield % | 2.19 | |||||
| 5-Year Yield-on-Cost % | 1.15 | |||||
| 3-Year Average Share Buyback Ratio | -2.2 | |||||
| Shareholder Yield % | 0.24 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.26 | |||||
| Operating Margin % | 23.07 | |||||
| Net Margin % | 20.18 | |||||
| FCF Margin % | -0.28 | |||||
| ROE % | 14.08 | |||||
| ROA % | 11.89 | |||||
| ROIC % | 14.11 | |||||
| ROC (Joel Greenblatt) % | 24.89 | |||||
| ROCE % | 15.28 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.17 | |||||
| PE Ratio without NRI | 12.17 | |||||
| Shiller PE Ratio | 15.26 | |||||
| Price-to-Owner-Earnings | 19.2 | |||||
| PEG Ratio | 1.6 | |||||
| PS Ratio | 2.46 | |||||
| PB Ratio | 1.62 | |||||
| Price-to-Tangible-Book | 2.24 | |||||
| Price-to-Operating-Cash-Flow | 11.01 | |||||
| EV-to-EBIT | 10.31 | |||||
| EV-to-EBITDA | 8.63 | |||||
| EV-to-Revenue | 2.37 | |||||
| EV-to-FCF | -842.07 | |||||
| Price-to-Projected-FCF | 1.28 | |||||
| Price-to-DCF (Earnings Based) | 0.59 | |||||
| Price-to-Median-PS-Value | 0.89 | |||||
| Price-to-Graham-Number | 1.26 | |||||
| Price-to-Net-Current-Asset-Value | 6.04 | |||||
| Earnings Yield (Greenblatt) % | 9.7 | |||||
| FCF Yield % | -0.12 | |||||
| Forward Rate of Return (Yacktman) % | 10.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Faes Farma SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 443.959 | ||
| EPS (TTM) (€) | 0.283 | ||
| Beta | 0.42 | ||
| Volatility % | 15.13 | ||
| 14-Day RSI | 81.54 | ||
| 14-Day ATR (€) | 0.061232 | ||
| 20-Day SMA (€) | 3.22525 | ||
| 12-1 Month Momentum % | -2.49 | ||
| 52-Week Range (€) | 2.865 - 3.47 | ||
| Shares Outstanding (Mil) | 311.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Faes Farma SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Faes Farma SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Faes Farma SA Frequently Asked Questions
What is Faes Farma SA(XMAD:FAE)'s stock price today?
The current price of XMAD:FAE is €3.45. The 52 week high of XMAD:FAE is €3.47 and 52 week low is €2.87.
When is next earnings date of Faes Farma SA(XMAD:FAE)?
The next earnings date of Faes Farma SA(XMAD:FAE) is .
Does Faes Farma SA(XMAD:FAE) pay dividends? If so, how much?
The Dividend Yield %  of Faes Farma SA(XMAD:FAE) is 1.15% (As of Today), Highest Dividend Payout Ratio of Faes Farma SA(XMAD:FAE) was 0.85. The lowest was 0.24. And the median was 0.71. The  Forward Dividend Yield % of Faes Farma SA(XMAD:FAE) is 2.19%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers